Contact Us Product Guide Drug Information Site Map
$67.62 -$0.08 (Down 0.03%) Volume: 1,846,200 Sep 03, 2008 Teva and Barr Receive FTC Request for Additional Information... Aug 28, 2008 Barr Receives Approval for Generic Version of Razadyne(R) Tablets... Sep 09, 2008 Barr Pharmaceuticals, Inc. at Morgan Stanley Global Healthcare Unplugged Conference Sep 17, 2008 Barr Pharmaceuticals, Inc. at Bank of America Securities Annual Investment Conference
Barr Pharmaceuticals, Inc.			Terms of Use Legal Notice Privacy Policy

Mission Corporate Profile Business Strategies Principal Facilities Government Affairs Corporate History

Generic Business Overview Barr Laboratories, Inc PLIVA d.d Generic Product Development Industry Links Clinical Trials

Proprietary Business Overview Proprietary Business Strategy Key Proprietary Products Proprietary Product Development Proprietary Sales Force Clinical Trials

Teva's Proposed Acquisition of Barr Corporate Profile Stock Quote Financials Fact Sheets Annual Reports 2008 Proxy Online Investor  Presentation Analyst Coverage Calendar Archives SEC Filings Corporate Governance Corporate Responsibility E-Mail Alerts Info Request

Career Opportunities Corporate Profile Mission Financials Generic Business Overview Key Generic Products Proprietary Business Overview Key Proprietary Products Proprietary Product Sales Forces